Process View
Any process that activates or increases the frequency, rate or extent of signal transduction by p53 class mediator.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of signal transduction by p53 class mediator"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) | 0.555 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.283 | ||
| HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 0.145 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.140 | ||
| HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 0.131 | ||
| RBM4 | RNA binding motif protein 4 | 0.117 | ||
| NBN | nibrin | 0.111 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.097 | ||
| WWOX | WW domain containing oxidoreductase | 0.092 | ||
| CREBBP | CREB binding protein | 0.087 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.077 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.070 | ||
| HIC2 | hypermethylated in cancer 2 | 0.066 | ||
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.060 | ||
| TOP1 | topoisomerase (DNA) I | 0.046 | ||
| MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.044 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.042 | ||
| EP300 | E1A binding protein p300 | 0.040 | ||
| NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive | 0.040 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.036 | ||
| TTN | titin | 0.036 | ||
| HUWE1 | HECT, UBA and WWE domain containing 1 | 0.034 | ||
| ATMIN | ATM interactor | 0.032 | ||
| HNRNPH2 | heterogeneous nuclear ribonucleoprotein H2 (H') | 0.031 | ||
| SRSF1 | serine/arginine-rich splicing factor 1 | 0.027 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.024 | ||
| MBNL1 | muscleblind-like (Drosophila) | 0.020 | ||
| HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 0.017 | ||
| TTC19 | tetratricopeptide repeat domain 19 | 0.016 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.015 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.015 | ||
| BRCA1 | breast cancer 1, early onset | 0.015 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.014 | ||
| TTI1 | Tel2 interacting protein 1 homolog (S. pombe) | 0.014 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.014 | ||
| TAF5L | TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa | 0.013 | ||
| BID | BH3 interacting domain death agonist | 0.013 | ||
| DCLRE1C | DNA cross-link repair 1C | 0.013 | ||
| RPP40 | ribonuclease P/MRP 40kDa subunit | 0.012 | ||
| ESR1 | estrogen receptor 1 | 0.012 | ||
| MSX2 | msh homeobox 2 | 0.012 | Human | |
| CRELD2 | cysteine-rich with EGF-like domains 2 | 0.011 | ||
| DEAF1 | deformed epidermal autoregulatory factor 1 (Drosophila) | 0.011 | ||
| MSX1 | msh homeobox 1 | 0.011 | ||
| ZNF420 | zinc finger protein 420 | 0.011 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.011 | ||
| WRN | Werner syndrome, RecQ helicase-like | 0.011 |